Now Reading: TG SAFE warns against unapproved weight-loss drugs sold online
-
01
TG SAFE warns against unapproved weight-loss drugs sold online
The Telangana Standards Authority for Food and Essential Drugs (TG SAFE) on Wednesday, 14 October 2026, issued a public advisory warning the public and doctors against procuring, prescribing, or self-administering unapproved weight-loss medications and experimental peptide products from unregulated online platforms and social media channels.
TG SAFE said certain medical practitioners and online vendors are distributing unapproved drugs like Retatrutide and Orforglipron, and experimental peptides such as Tesamorelin, BPC-157, and GHK-Cu. Many of these items are falsely marketed as ‘research chemicals’ or labelled ‘Not for Human Consumption’ yet sold with injection kits.
The regulator warned such products lack regulatory approvals, bypass sterility and quality controls, and pose severe health risks including life-threatening complications. Doctors have been warned against prescribing unapproved formulations in violation of the Drugs and Cosmetics Act, 1940. The public can report instances to the TG SAFE Drugs Wing toll-free number 1800-599-6969 on working days between 10.30 am and 5 pm.
Indian Opinion Analysis
The advisory targets a grey market in unapproved injectable drugs and peptides sold openly online, often with delivery of injection kits. TG SAFE explicitly names specific drugs and peptides, signalling it has gathered evidence of active distribution. The warning places responsibility on doctors not to prescribe these substances, while also giving the public a direct reporting channel. The toll-free number and working hours suggest the regulator expects ongoing complaints and intends to act on them.
Source: telanganatoday.com
This brief was synthesised by AI from the source linked above. Methodology and corrections.
